DigiTx Partners

Cerula Care is a behavioral health company that focuses on providing services for individuals with advanced chronic conditions. The company offers virtual care solutions, including care management, coaching, and psychiatric support, aimed at addressing mental health issues such as anxiety, depression, substance use disorder, and post-traumatic stress disorder. By leveraging these services, Cerula Care seeks to enhance behavioral health outcomes for its patients, ensuring they receive comprehensive support tailored to their specific needs.

StrokeDx is a company that specializes in the development of innovative and portable diagnostic devices aimed at revolutionizing stroke care. Through the use of advanced microsensors and artificial intelligence, StrokeDx's products can quickly detect blood presence in the brain, generating predictive images of stroke locations after scanning. This technology significantly reduces the time to treatment for stroke patients and is designed to be more cost-effective than traditional diagnostic methods. The company employs a dedicated software engineering team focused on creating novel algorithms that enhance the diagnostic accuracy and imaging capabilities of its devices, ultimately improving the triage and diagnosis process for healthcare providers.

CardioSignal is a medical technology company focused on the detection of heart diseases, particularly atrial fibrillation. Originally an academic spinoff, it has developed a patented mobile application that serves as a certified medical device for self-monitoring, remote care, and point-of-care diagnostics. The application utilizes advanced algorithms to provide users with features such as atrial fibrillation detection, vital signs monitoring, measurement history, and personalized insights. By enabling users to track their heart health, CardioSignal aims to facilitate early detection and prevention of serious cardiovascular events such as strokes and heart attacks, ultimately improving patient outcomes.

Rune Labs, Inc. is a technology company that offers a software-as-a-service platform designed to support neuromodulation systems in managing complex therapies. Established in 2018 and headquartered in San Francisco, California, the platform integrates brain imaging and electrophysiology data from clinical studies and patient care, making it valuable for neuroscience therapeutics. Rune Labs primarily serves pharmaceutical and med-tech companies, assisting them in developing precision therapies for conditions such as Parkinson's disease, epilepsy, depression, and obsessive-compulsive disorder. The platform provides a secure, cloud-based infrastructure that enables clients to efficiently analyze large volumes of brain data, facilitating the implementation of sophisticated therapy algorithms and enhancing the precision of medicine delivered to patients.

Ciba Health is a personalized digital therapeutics and virtual care platform that focuses on treating and reversing chronic conditions through a precision health approach. The company empowers patients by promoting self-care and offering a patient-centered, root-cause methodology. Ciba Health emphasizes a value-based care delivery model that integrates full-spectrum care, providing convenient access to multidisciplinary teams. By leveraging advanced technology, it implements individualized treatment plans that address the physical, mental, and lifestyle needs of patients, fostering improvements in overall well-being.

Tali AI offers a voice-enabled virtual assistant for healthcare professionals. It automates clinical documentation by dictating notes directly into electronic health records (EHR), reducing administrative workloads and allowing providers to focus more on patient care.

FIGUR8, Inc. is a Boston-based company founded in 2016 as an MIT spin-off, specializing in advanced wearable sensor technology to measure body movement related to musculoskeletal (MSK) conditions. The company's innovative solution integrates smart biosensors, intuitive software, and artificial intelligence to collect and analyze movement data without the need for cumbersome cameras. This technology accurately identifies the sources of MSK pathology, providing essential insights that enhance patient recovery and care management. By enabling trainers, therapists, and physicians to objectively assess musculoskeletal performance, FIGUR8's platform not only improves access to care but also empowers patients to take control of their health. The comprehensive approach records value throughout the entire episode of care, from injury to recovery, ultimately reducing costs and improving health outcomes.

Mightier is a Boston-based company that develops bioresponsive video games and a family program designed to help children regulate emotions. The platform pairs gameplay with a biofeedback heart rate monitor to adjust game difficulty, encouraging kids to stay calm and in control while learning to recognize and manage emotions in daily life. Created through collaboration with Boston Children's Hospital and Harvard Medical School, Mightier aims to address behavioral and emotional challenges by teaching real-time emotion regulation skills. Founded in 2016, the company offers a program that integrates mind-body signals into interactive experiences, enabling children to practice emotional control through engaging, age-appropriate games.

Rune Labs, Inc. is a technology company that offers a software-as-a-service platform designed to support neuromodulation systems in managing complex therapies. Established in 2018 and headquartered in San Francisco, California, the platform integrates brain imaging and electrophysiology data from clinical studies and patient care, making it valuable for neuroscience therapeutics. Rune Labs primarily serves pharmaceutical and med-tech companies, assisting them in developing precision therapies for conditions such as Parkinson's disease, epilepsy, depression, and obsessive-compulsive disorder. The platform provides a secure, cloud-based infrastructure that enables clients to efficiently analyze large volumes of brain data, facilitating the implementation of sophisticated therapy algorithms and enhancing the precision of medicine delivered to patients.

Cleerly is a healthcare company focused on transforming the management of coronary artery disease through innovative digital care pathways aimed at preventing heart attacks. By combining advanced clinical science with state-of-the-art artificial intelligence, Cleerly develops a platform that delivers actionable clinical insights for all stakeholders involved in heart care. This platform employs a non-invasive approach to analyze and characterize plaque buildup in coronary arteries, allowing healthcare providers to better identify at-risk patients and facilitate early treatment. Cleerly's data-driven solutions not only enhance the evaluation of cardiovascular disease but also aim to improve patient heart health while delivering value to the healthcare system.

Nēsos specializes in the development and commercialization of electrical field treatments aimed at addressing neurological disorders. The company focuses on creating therapeutic earbuds that facilitate drug-free, non-invasive treatments by utilizing existing nerve pathways to stimulate target brain regions. This innovative approach enables medical practitioners to treat conditions such as rheumatoid arthritis by harnessing the principles of neuroplasticity. Nēsos benefits from the collaboration of prominent clinical and scientific experts from esteemed academic institutions, including Stanford, Harvard, and Mount Sinai, among others. Co-founded by Konstantinos Alataris and a team of neuroscientists, Nēsos is committed to advancing therapies that improve immune function and overall neurological health.

Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Rune Labs, Inc. is a technology company that offers a software-as-a-service platform designed to support neuromodulation systems in managing complex therapies. Established in 2018 and headquartered in San Francisco, California, the platform integrates brain imaging and electrophysiology data from clinical studies and patient care, making it valuable for neuroscience therapeutics. Rune Labs primarily serves pharmaceutical and med-tech companies, assisting them in developing precision therapies for conditions such as Parkinson's disease, epilepsy, depression, and obsessive-compulsive disorder. The platform provides a secure, cloud-based infrastructure that enables clients to efficiently analyze large volumes of brain data, facilitating the implementation of sophisticated therapy algorithms and enhancing the precision of medicine delivered to patients.

G-Tech Medical is focused on developing a wireless, wearable, and disposable electrode patch known as the GutCheck patch, which measures the electrical activity of the gastrointestinal tract, specifically the stomach, small intestine, and colon. This innovative diagnostic device addresses the challenges of diagnosing functional disorders in patients experiencing abdominal pain, constipation, diarrhea, or bloating, conditions that often go undetected through traditional methods like colonoscopies or CT scans. By monitoring myoelectrical signals over several days, G-Tech's system provides a non-invasive solution that enables physicians to assess gastrointestinal motility more effectively, ultimately aiming to enhance patient outcomes and reduce healthcare costs associated with gastrointestinal conditions.

nQ Medical Inc., founded in 2016 and based in Cambridge, Massachusetts, is a digital therapeutics company focused on transforming the management of neurocognitive and neuromotor disorders. The company has developed an artificial intelligence tool called neuroQWERTY that facilitates early detection and remote monitoring of diseases such as Alzheimer's, Parkinson's, and multiple sclerosis. By passively collecting data from users' interactions with everyday electronic devices, nQ Medical captures subtle changes in motor function and cognitive abilities that may indicate disease progression. This innovative approach allows for continuous, non-invasive monitoring without requiring specific tasks from users, making it a cost-effective alternative to traditional diagnostic methods. The platform not only diagnoses conditions but also tracks therapeutic effectiveness, enabling better communication between clinicians and patients. By focusing on early detection and reliable disease progression markers, nQ Medical aims to enhance the management of neurological disorders and prepare for the future introduction of disease-modifying therapies.

Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Embr Labs Inc. is a thermal wellness technology company based in Somerville, Massachusetts, that specializes in developing and selling wearable devices designed to adjust body temperature for enhanced comfort. Originally founded as Wristify Inc. in 2014, the company rebranded in 2015. Embr Labs leverages patented technology to utilize thermal sensations as a means to influence the autonomic nervous system, aiding individuals in managing conditions such as hot flashes, sleep disturbances, and anxiety. The company's innovative approach combines thermal stimulation with digital interventions through a mobile app and cloud infrastructure, creating a comprehensive platform for users. With tens of thousands of customers across 170 countries, Embr Labs has recorded over 100 million minutes of thermal interventions. The technology was conceived by its founders while they were engineering students at MIT, and the company has received significant backing from various investors and grants.

Neosensory, Inc. is a company that specializes in developing wearable devices aimed at enhancing sensory perception for individuals. Founded in 2015 and based in San Mateo, California, Neosensory offers products such as Buzz, which utilizes vision-to-touch sensory substitution technology to assist blind individuals. The company focuses on transmitting various data streams to the brain through the sense of touch, leveraging the skin's potential for information delivery. Their innovative approach includes building hearing assistive technology that allows users to perceive sound through vibrations on the skin. Neosensory also provides a companion application for its products, enhancing the user experience and accessibility of information.

Savonix develops an evidence-based digital neuro-cognitive assessment and brain health platform. Its Savonix Mobile enables individuals to conduct clinically recognized cognitive assessments on smartphones or tablets, with results usable by patients, clinicians, employers, and healthcare providers to guide brain health decisions. The company offers a suite of tools to interpret results and support monitoring, diagnosis, and treatment planning. It has partnerships with New York University, CereScan, Proove Biosciences, Alkahest, and Senescence Life Sciences. Founded in 2014 and based in San Francisco, Savonix tests cognitive domains from memory to implicit learning, including a 3D game platform that derives novel metrics from in-app performance. The platform supports early detection of cognitive change and dementia risk, and serves doctors, researchers, insurers, and government clients with accessible, scalable cognitive screening.

LifeLink Systems develops a conversational AI platform that enables healthcare providers, payers, and pharmaceutical companies to engage patients through mobile and messaging channels. The platform deploys chatbots that automate key touchpoints before, during, and after care visits, delivering personalized, natural, and contextual conversations. By automating these interactions, LifeLink improves operational efficiency, boosts patient satisfaction, and strengthens brand loyalty while ensuring secure, compliant communication. The solution supports hospitals and care organizations in meeting patients where they prefer, enhancing engagement and profitability.

Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Tissue Analytics, Inc. is a Baltimore-based company that specializes in developing a mobile application aimed at improving the management of chronic wounds, burns, and skin conditions. Founded in 2014, the company provides a solution for home health agencies, nursing homes, and medical practices to capture patient photographs and perform wound analysis. The platform automatically generates formatted patient reports and enables tracking of treatment progress. It also includes remote evaluation tools and employs advanced algorithms for skin and wound analysis, ensuring secure transmission of protected health information from patients to healthcare providers. Tissue Analytics operates as a subsidiary of Net Health Systems, Inc. and has formed a strategic alliance with MolecuLight Inc.

Founded in 2013, Siris Medical specializes in artificial intelligence-driven treatment decision support systems for radiation therapy in cancer patients. Its flagship product, InsightRT Software Suite, enables efficient management of patient data and offers tools like QuickMatch and PlanMD for personalized treatment recommendations.

Savonix develops an evidence-based digital neuro-cognitive assessment and brain health platform. Its Savonix Mobile enables individuals to conduct clinically recognized cognitive assessments on smartphones or tablets, with results usable by patients, clinicians, employers, and healthcare providers to guide brain health decisions. The company offers a suite of tools to interpret results and support monitoring, diagnosis, and treatment planning. It has partnerships with New York University, CereScan, Proove Biosciences, Alkahest, and Senescence Life Sciences. Founded in 2014 and based in San Francisco, Savonix tests cognitive domains from memory to implicit learning, including a 3D game platform that derives novel metrics from in-app performance. The platform supports early detection of cognitive change and dementia risk, and serves doctors, researchers, insurers, and government clients with accessible, scalable cognitive screening.

Juji is a company focused on democratizing artificial intelligence to enhance human interaction and automation. It offers a cloud-based software platform that enables users to create customized AI chatbots without requiring technical expertise. By leveraging advanced technologies such as deep learning, natural language processing, and machine learning, Juji's platform allows business professionals to integrate chatbots into websites and mobile applications. These chatbots can perform various functions, including greeting visitors, understanding their needs, answering queries, and providing enterprise information. Additionally, the platform provides real-time audience analytics, including topic summarization of user interactions, facilitating informed decision-making for clients.

FITNESS & WELLNESS TRACKING MODULES All our platforms offer Bluetooth Smart (Low Energy) wireless, USB charging and data connectivity, Flash memory, and a choice of processing power & of sensors. -Now: 16 bit MCU and gyroscopes, accelerometers, compass, pressure & temperature sensors. -In Q2 2014: 32 bit MCU and, in addition to the above sensors, optional ones such as heart rate, oxygen, humidity, UV, muscle strain, etc.